Etrasimod: Data from P2b CULTIVATE trial (NCT04173273) for Crohn's disease in mid-2021 (Arena) - Jun 18, 2020 - Corporate Presentation: Data from P3 trial for Crohn's disease in H2 2022
P2b data • P3 data • Crohn's disease • Inflammatory Bowel Disease • Ulcerative Colitis
|